Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Narod

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2019
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer RiskBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Endometriosis in Carriers of a Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>: A Descriptive Analysis of a Large Multicentral <i>BRCA</i> Carrier CohortAghaghia Mokhber, Brynne Stewart, Kathryn L Terry, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2007
Breast cancer susceptibility genesJan Lubinski, Marcin Korzen, Bohdan Gorski, et al.
Breast Cancer Research and Treatment|April 17, 2008
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathologyJan Lubiński, Marcin Korzeń, Bohdan Górski, et al.
Hereditary Cancer in Clinical Practice|September 19, 2024
Blood molybdenum level as a marker of cancer risk on BRCA1 carriersMilena Matuszczak, Adam Kiljańczyk, Wojciech Marciniak, et al.
International Journal of Cancer|January 6, 2006
CDKN2A common variant and multi-organ cancer risk--a population-based studyTadeusz Debniak, Rodney J Scott, Tomasz Huzarski, et al.
Annals of Surgical Oncology|June 25, 2024
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT<sup>®</sup> PREDICT StudyChirag Shah, Pat Whitworth, Frank A Vicini, et al.
Nature Genetics|April 23, 2002
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsHanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Proceedings of the National Academy of Sciences of the United States of America|March 11, 2008
Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33Bert Gold, Tomas Kirchhoff, Stefan Stefanov, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 6, 2019
Genome-wide Analysis of Common Copy Number Variation and Epithelial Ovarian Cancer RiskBrett M Reid, Jennifer B Permuth, Y Ann Chen, et al.
Current Oncology (Toronto, Ont.)|December 24, 2025
Endometriosis in Carriers of a Pathogenic Variant in <i>BRCA1</i> or <i>BRCA2</i>: A Descriptive Analysis of a Large Multicentral <i>BRCA</i> Carrier CohortAghaghia Mokhber, Brynne Stewart, Kathryn L Terry, et al.
Journal of B.U.ON. : Official Journal of the Balkan Union of Oncology|November 6, 2007
Breast cancer susceptibility genesJan Lubinski, Marcin Korzen, Bohdan Gorski, et al.
Breast Cancer Research and Treatment|April 17, 2008
Genetic contribution to all cancers: the first demonstration using the model of breast cancers from Poland stratified by age at diagnosis and tumour pathologyJan Lubiński, Marcin Korzeń, Bohdan Górski, et al.
Hereditary Cancer in Clinical Practice|September 19, 2024
Blood molybdenum level as a marker of cancer risk on BRCA1 carriersMilena Matuszczak, Adam Kiljańczyk, Wojciech Marciniak, et al.
International Journal of Cancer|January 6, 2006
CDKN2A common variant and multi-organ cancer risk--a population-based studyTadeusz Debniak, Rodney J Scott, Tomasz Huzarski, et al.
Annals of Surgical Oncology|June 25, 2024
The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT<sup>®</sup> PREDICT StudyChirag Shah, Pat Whitworth, Frank A Vicini, et al.
Nature Genetics|April 23, 2002
Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutationsHanne Meijers-Heijboer, Ans van den Ouweland, Jan Klijn, et al.
European Journal of Cancer (Oxford, England : 1990)|February 12, 2021
Clinical practice guidelines for BRCA1 and BRCA2 genetic testingPascal Pujol, Massimo Barberis, Philp Beer, et al.
Pageof 10